Geoffrey Uy

35PUBLICATIONS
205CO-AUTHORS
Regenerative medicine (incl. stem cells)Cardiovascular medicine and haematology not elsewhere classifiedApplications in healthHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Jul 06, 2026
Decentralized Clinical Trials in Hematology: the Promise and the Peril.

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Feb 02, 2026
CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial.

Shai Shimony, H Moses Murdock, Julia H Keating

|Jan 29, 2026
Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML.

Jeremy T Baeten, Sumedha Agashe, Imene Tabet

Pageof 6

Frequent Collaborators

7 joint publications

Mark R Litzow

5 joint publications

Krzysztof Mrózek

5 joint publications

James S Blachly

5 joint publications

Wendy Stock